PGRCX
Price
$46.97
Change
-$0.30 (-0.63%)
Updated
Jan 14 closing price
Net Assets
1.01B
RNPFX
Price
$72.11
Change
-$0.44 (-0.61%)
Updated
Jan 14 closing price
Net Assets
162.72B
Interact to see
Advertisement

PGRCX vs RNPFX

Header iconPGRCX vs RNPFX Comparison
Open Charts PGRCX vs RNPFXBanner chart's image
BNY Mellon Worldwide Growth C
Price$46.97
Change-$0.30 (-0.63%)
VolumeN/A
Net Assets1.01B
American Funds New Perspective R5
Price$72.11
Change-$0.44 (-0.61%)
VolumeN/A
Net Assets162.72B
PGRCX vs RNPFX Comparison Chart in %
View a ticker or compare two or three
VS
PGRCX vs. RNPFX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGRCX is a Hold and RNPFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPFX has more cash in the bank: 163B vs. PGRCX (1.01B). RNPFX pays higher dividends than PGRCX: RNPFX (1.27) vs PGRCX (0.00). PGRCX was incepted earlier than RNPFX: PGRCX (31 years) vs RNPFX (24 years). PGRCX (1.89) is less costly to investors than RNPFX (0.46). RNPFX is a more actively managed with annual turnover of: 24.00 vs. PGRCX (13.83). RNPFX has a lower initial minimum investment than PGRCX: RNPFX (250) vs PGRCX (1000). RNPFX annual gain was more profitable for investors over the last year : 18.48 vs. PGRCX (-7.59). RNPFX return over 5 years is better than : 21.51 vs. PGRCX (-12.24).
PGRCXRNPFXPGRCX / RNPFX
Total Expense Ratio1.890.46411%
Annual Report Gross Expense Ratio1.890.46411%
Fund Existence31 years24 years-
Gain YTD0.8372.22638%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.01B163B1%
Annual Yield % from dividends0.001.27-
Returns for 1 year-7.5918.48-41%
Returns for 3 years-3.0348.43-6%
Returns for 5 years-12.2421.51-57%
Returns for 10 years16.25130.6412%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDYA37.031.94
+5.53%
IDEAYA Biosciences
ELTX8.030.26
+3.35%
Elicio Therapeutics
MPB31.630.31
+0.99%
Mid Penn Bancorp
XPON0.93N/A
+0.19%
Expion360 Inc
LITE331.62-29.71
-8.22%
Lumentum Holdings